Why Did Progressive Stock Go Down?
Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…
Buy
70
NHI Quote, Financials, Valuation and Earnings
Last price:
$74.70
Seasonality move
:
3.54%
Day range:
$73.39 - $74.99
52-week range:
$57.80 - $86.13
Dividend yield:
4.82%
P/E ratio:
23.94x
P/S ratio:
9.83x
P/B ratio:
2.50x
Volume:
155.7K
Avg. volume:
249.1K
1-year change:
21.86%
Market cap:
$3.4B
Revenue:
$335.2M
EPS (TTM):
$3.12
Analysts' Opinion
-
Consensus RatingNational Health Investors has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $82.14, National Health Investors has an estimated upside of 9.96% from its current price of $74.70.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $68.00 representing 8.97% downside risk from its current price of $74.70.
Fair Value
-
According to the consensus of 7 analysts, National Health Investors has 9.96% upside to fair value with a price target of $82.14 per share.
NHI vs. S&P 500
-
Over the past 5 trading days, National Health Investors has underperformed the S&P 500 by -2.63% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
National Health Investors does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
National Health Investors has grown year-over-year revenues for 3 quarters straight. In the most recent quarter National Health Investors reported revenues of $85.8M.
Earnings Growth
-
National Health Investors has grown year-over-year earnings for 1 quarter straight. In the most recent quarter National Health Investors reported earnings per share of $0.95.
Enterprise value:
4.6B
EV / Invested capital:
1.80x
Price / LTM sales:
9.83x
EV / EBIT:
23.63x
EV / Revenue:
13.58x
PEG ratio (5yr expected):
1.24x
EV / Free cash flow:
22.35x
Price / Operating cash flow:
16.17x
Enterprise value / EBITDA:
17.24x
Gross Profit (TTM):
$324M
Return On Assets:
5.51%
Net Income Margin (TTM):
41.17%
Return On Equity:
10.72%
Return On Invested Capital:
5.69%
Operating Margin:
50.04%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $278.2M | $319.8M | $335.2M | $79.5M | $85.8M | |
| Gross Profit | $268.4M | $308.3M | $324M | $76.7M | $82.9M | |
| Operating Income | $132.8M | $178.8M | $183.9M | $44.7M | $42.9M | |
| EBITDA | $178.7M | $259.9M | $264.2M | $63M | $75.4M | |
| Diluted EPS | $1.47 | $3.13 | $3.12 | $0.74 | $0.95 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $446.8M | $514.8M | $383M | $375.2M | $396.9M | |
| Total Assets | $3.1B | $2.8B | $2.5B | $2.5B | $2.6B | |
| Current Liabilities | $87.6M | $70.2M | $112M | $324.4M | $414.4M | |
| Total Liabilities | $1.6B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Total Equity | $1.5B | $1.5B | $1.3B | $1.3B | $1.4B | |
| Total Debt | $1.5B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $185.3M | $184.5M | $207.8M | $53.2M | $57.6M | |
| Cash From Investing | $197.9M | -$11.6M | -$192.3M | $2.3M | -$161.2M | |
| Cash From Financing | -$401.3M | -$169.7M | -$13.6M | -$49.4M | $112.4M | |
| Free Cash Flow | $185.3M | $180.7M | $203.7M | $52M | $57.1M | |
NHI
Sector
Market Cap
$3.4B
$1B
Price % of 52-Week High
86.73%
80.59%
Dividend Yield
4.82%
3.32%
Shareholder Yield
--
3.41%
1-Year Price Total Return
21.86%
-1.68%
Beta (5-Year)
1.083
0.886
Dividend yield:
4.82%
Annualized payout:
$3.60
Payout ratio:
113.43%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$74.79
200-day SMA
Buy
Level
$73.85
Bollinger Bands (100)
Buy
Level
68.45 - 76.43
Chaikin Money Flow
Buy
Level
49.9M
20-day SMA
Buy
Level
$73.17
Relative Strength Index (RSI14)
Buy
Level
58.73
ADX Line
Buy
Level
24.81
Williams %R
Neutral
Level
-35.0698
50-day SMA
Buy
Level
$70.24
MACD (12, 26)
Buy
Level
1.36
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
48.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.3038)
Buy
CA Score
(Annual)
Level (-0.0117)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.2636)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.
Stock Forecast FAQ
In the current month, NHI has received 3 Buy ratings 4 Hold ratings, and 0 Sell ratings. The NHI average analyst price target in the past 3 months is $82.14.
-
Where Will National Health Investors Stock Be In 1 Year?
According to analysts, the consensus estimate is that National Health Investors share price will rise to $82.14 per share over the next 12 months.
-
What Do Analysts Say About National Health Investors?
Analysts are divided on their view about National Health Investors share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that National Health Investors is a Sell and believe this share price will drop from its current level to $68.00.
-
What Is National Health Investors's Price Target?
The price target for National Health Investors over the next 1-year time period is forecast to be $82.14 according to 7 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is NHI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for National Health Investors is a Hold. 4 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of NHI?
You can purchase shares of National Health Investors via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase National Health Investors shares.
-
What Is The National Health Investors Share Price Today?
National Health Investors was last trading at $74.70 per share. This represents the most recent stock quote for National Health Investors. Yesterday, National Health Investors closed at $74.70 per share.
-
How To Buy National Health Investors Stock Online?
In order to purchase National Health Investors stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did StoneCo Stock Go Up So Much?
Brazilian fintech company StoneCo (NASDAQ:STNE) has been on a tear…
Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
47
RGC alert for Mar 25
Regencell Bioscience Holdings [RGC] is down 28.36% over the past day.
Buy
58
TNXP alert for Mar 25
Tonix Pharmaceuticals Holding [TNXP] is up 32.39% over the past day.
Buy
54
AZEK alert for Mar 25
The AZEK [AZEK] is up 17.3% over the past day.
